The [alpha]-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin

Objective: Voglibose is a new and potent inhibitor of α-glucosidases and is used for the treatment of diabetes mellitus. Since voglibose increases gastrointestinal motility and could thus affect absorption of concomitantly administered drugs, it was investigated whether or not voglibose modifies the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of clinical pharmacology 1997-10, Vol.53 (2), p.153
Hauptverfasser:	Fuder, H, Kleist, P, Birkel, M, Ehrlich, A, Emeklibas, S, Maslak, W, Stridde, E, Wetzelsberger, N, Wieckhorst, G, Lücker, P W
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!